ARES LIFE SCIENCES
Ares Life Sciences AG is a venture capital firm specializing in expansion and late stage investments. The firm seeks to invest in life sciences sector with a focus on pharmaceuticals, biotechnology, diagnostics, medical technology, and healthcare services. In pharmaceuticals, it seeks to invest in innovative drugs, generics, and specialty to OTC. In biotechnology, it seeks to invest in in novel biological products and biosimilars.
Similar Organizations
Excalibur Fund Managers
Excalibur Fund Managers is a venture capital firm specializing in early, mid, and late stage investments.
MVM Life Science Partners
MVM Life Science Partners is a venture capital firm specializing in investments in start-up, early stage, mid venture, late venture.
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2014-10-06 | Affidea | Affidea acquired by Ares Life Sciences | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2008-12-05 | Broncus Technologies | Ares Life Sciences investment in Series G - Broncus Technologies | 38 M USD |
| 2008-11-06 | Santhera Pharmaceuticals | Ares Life Sciences investment in Post-IPO Equity - Santhera Pharmaceuticals | 15.9 M CHF |